Carbon dioxide-dependent, extended-spectrum β-lactamase producing Escherichia coli bacteremia associated with pyelonephritis: A case-report

J Infect Chemother. 2025 Feb;31(2):102542. doi: 10.1016/j.jiac.2024.10.010. Epub 2024 Oct 16.

Abstract

Escherichia coli is a facultative anaerobic bacterium that causes urinary tract and bloodstream infections. Generally, E. coli is easily identified in routine clinical microbiology laboratories. Herein, we report a case of pyelonephritis with bacteremia due to extended-spectrum β-lactamase (ESBL) producing E. coli, which delayed the identification of the isolate as it exhibited carbon dioxide (CO2)-dependent growth. The patient was a 62-year-old man who presented with nausea and an altered mental status. Contrast-enhanced computed tomography revealed multiple abscesses in the left kidney. The anaerobic bottles of the two sets of blood cultures were positive, but growth on a routine aerobic culture was weak. Identification of the isolate was delayed because it grew only on agar plates incubated in a 5 % CO2 atmosphere. The isolate was suspected to be an ESBL-producing strain based on antimicrobial susceptibility testing, which was confirmed by polymerase chain reaction analysis. The patient was successfully treated with administering meropenem and nephrectomy. To the best-of-our-knowledge, this is the first reported case of a human infection caused by ESBL-producing carbon-dioxide-dependent E. coli.

Keywords: Carbon dioxide-dependent bacteria; Escherichia coli; Extended-spectrum β-lactamase (ESBL)-Producing bacteria; Pyelonephritis; Small colony variants.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Bacteremia* / microbiology
  • Carbon Dioxide / metabolism
  • Escherichia coli Infections* / diagnosis
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / microbiology
  • Escherichia coli* / drug effects
  • Escherichia coli* / isolation & purification
  • Humans
  • Male
  • Meropenem* / therapeutic use
  • Microbial Sensitivity Tests
  • Middle Aged
  • Nephrectomy
  • Pyelonephritis* / diagnosis
  • Pyelonephritis* / drug therapy
  • Pyelonephritis* / microbiology
  • Thienamycins / therapeutic use
  • beta-Lactamases* / metabolism

Substances

  • beta-Lactamases
  • Anti-Bacterial Agents
  • Meropenem
  • Carbon Dioxide
  • Thienamycins